4//SEC Filing
Lea Darrell Shane 4
Accession 0001104659-24-072885
CIK 0001279704other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 5:02 PM ET
Size
6.1 KB
Accession
0001104659-24-072885
Insider Transaction Report
Form 4
Lea Darrell Shane
Chief Commercial Officer
Transactions
- Award
Stock option (right to buy)
2024-06-14+260,000→ 260,000 totalExercise: $2.65Exp: 2033-12-15→ Common Stock (260,000 underlying)
Footnotes (2)
- [F1]This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024.
- [F2]This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023.
Documents
Issuer
Cellectar Biosciences, Inc.
CIK 0001279704
Entity typeother
Related Parties
1- filerCIK 0001958526
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 5:02 PM ET
- Size
- 6.1 KB